Stay updated with breaking news from Website Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
<h4><i>Delegates to the Minamata Convention on Mercury address triple planetary crisis with fluorescent lamp phase-out.</i></h4><p/>GENEVA, SWITZERLAND - News Direct - 4 November 2023 - <br/> <br/> This week at the Minamata Convention on Mercury Fifth Conference of Parties (COP5), delegates from 147 countries agreed to phase out florescent lighting globally and completely by 2027.
<p>New York, New York - <a href="https://www.newsfilecorp.com/">Newsfile Corp.</a> - November 4, 2023 - <b>WHY:</b> Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Barclays PLC (NYSE: BCS) (OTC Pink: BCLYF) between July 22, 2019 and October 12, 2023, both dates inclusive (the "Class Period").</p>
<p>Phoenix, Arizona - <a href="https://www.newsfilecorp.com/">Newsfile Corp.</a> - November 2, 2023 - Greenbriar Capital Corp. (TSXV: GRB) (OTC Pink: GEBRF) ("Greenbriar" or the "Company") is pleased to announce that effective <b>November 15, 2023</b> the Company will change its name to "Greenbriar Sustainable Living Inc.</p>
<ul> <li> <b>Thailand's entertainment industry is forecast to achieve revenues of USD16.5 billion by 2025, with a CAGR of 4.5% from 2021 to 2025</b> </li> </ul> <br/> SINGAPORE - <a href="https://www.media-outreach.com/">Media OutReach</a> - 1 November 2023 - NoonTalk Media Limited, a Singapore-based media entertainment company specialising in artiste and talent management, multimedia, film and drama production, as well as event conceptualisation and management, is pleased to announce that it has signed on three Thai arti...
<p>HONG KONG SAR - <a href="https://www.media-outreach.com/">Media OutReach</a> - 1 November 2023 - CK Life Sciences Int'l., (Holdings) Inc. is presenting preclinical data for its investigational dual-antigen cancer vaccines, co-targeting PRAME (preferentially expressed antigen in melanoma) and PD-L1 (programmed death-ligand 1), on November 4<b> </b>at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting in San Diego, California, USA.</p>